Vanguard Global Advisers
AVNS

Vanguard Global Advisers’s Avanos Medical AVNS Stock Holding History

Vanguard Global Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
18,285
-109,952
-86% -$2.57M ﹤0.01% 2148
2026
Q1 		$1.8M Buy
+128,237
New +$1.73M ﹤0.01% 1260

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Global Advisers's AVNS Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Avanos Medical (AVNS) stake by 86% in Q2 2026, selling an estimated $2.57M and leaving 18,285 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Vanguard Global Advisers first reported a position in AVNS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.8M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Vanguard Global Advisers held 18,285 shares of Avanos Medical worth $455K as of Q2 2026.
  • Vanguard Global Advisers sold 109,952 Avanos Medical shares in Q2 2026, an estimated $2.57M.
  • Avanos Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2148 holding.
  • Vanguard Global Advisers first reported a position in Avanos Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Avanos Medical position peaked at $1.8M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.